lobbying_activities: 2182349

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2182349	f20c9597-84bf-44dc-b3bc-ef3de7a0a942	Q3	CAPITOL HILL CONSULTING GROUP	72053	PURDUE PHARMA LLP	2018	third_quarter	PHA	Controlled Drug Substances Act (21 USC 13)	Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2018-10-11T11:08:03.083000-04:00